Trinity Biotech Plc (TRIB)
6.315
-0.44
(-6.44%)
USD |
NASDAQ |
Oct 08, 12:27
Trinity Biotech Total Liabilities (Quarterly)
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 177.15M |
| September 30, 2025 | 158.43M |
| June 30, 2025 | 149.17M |
| March 31, 2025 | 143.41M |
| December 31, 2024 | 138.47M |
| September 30, 2024 | 123.79M |
| June 30, 2024 | 123.76M |
| March 31, 2024 | 113.16M |
| December 31, 2023 | 83.38M |
| September 30, 2023 | 81.08M |
| June 30, 2023 | 83.37M |
| March 31, 2023 | 97.78M |
| December 31, 2022 | 94.28M |
| September 30, 2022 | 91.26M |
| June 30, 2022 | 91.32M |
| March 31, 2022 | 112.38M |
| December 31, 2021 | 119.21M |
| September 30, 2021 | 121.97M |
| June 30, 2021 | 125.22M |
| March 31, 2021 | 136.11M |
| December 31, 2020 | 132.62M |
| September 30, 2020 | 129.00M |
| June 30, 2020 | 129.44M |
| March 31, 2020 | 128.36M |
| December 31, 2019 | 126.36M |
| Date | Value |
|---|---|
| September 30, 2019 | 134.32M |
| June 30, 2019 | 132.63M |
| March 31, 2019 | 128.48M |
| December 31, 2018 | 107.60M |
| September 30, 2018 | 115.24M |
| June 30, 2018 | 127.76M |
| March 31, 2018 | 128.90M |
| December 31, 2017 | 127.78M |
| September 30, 2017 | 138.24M |
| June 30, 2017 | 137.93M |
| March 31, 2017 | 135.86M |
| December 31, 2016 | 141.64M |
| September 30, 2016 | 150.07M |
| June 30, 2016 | 147.11M |
| March 31, 2016 | 147.56M |
| December 31, 2015 | 149.79M |
| September 30, 2015 | 144.38M |
| June 30, 2015 | 154.70M |
| March 31, 2015 | 45.54M |
| December 31, 2014 | 44.48M |
| September 30, 2014 | 40.60M |
| June 30, 2014 | 42.34M |
| March 31, 2014 | 39.90M |
| December 31, 2013 | 43.48M |
| September 30, 2013 | 47.75M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| DBV Technologies SA | 62.80M |
| Cellectis SA | 226.30M |
| Akari Therapeutics Plc | 20.03M |
| Autolus Therapeutics Plc | 418.39M |
| Evaxion AS | 9.849M |
Total Liabilities (Quarterly) Related Metrics
| Debt to Equity Ratio | -1.917 |
| Current Ratio | 0.2542 |
| Net Debt Paydown Yield | 192.2% |